146 related articles for article (PubMed ID: 31726465)
1. CX3CR1 as a respiratory syncytial virus receptor in pediatric human lung.
Anderson CS; Chu CY; Wang Q; Mereness JA; Ren Y; Donlon K; Bhattacharya S; Misra RS; Walsh EE; Pryhuber GS; Mariani TJ
Pediatr Res; 2020 Apr; 87(5):862-867. PubMed ID: 31726465
[TBL] [Abstract][Full Text] [Related]
2. CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
Green G; Johnson SM; Costello H; Brakel K; Harder O; Oomens AG; Peeples ME; Moulton HM; Niewiesk S
J Virol; 2021 Jul; 95(16):e0001021. PubMed ID: 34037420
[TBL] [Abstract][Full Text] [Related]
3. CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.
Chirkova T; Lin S; Oomens AGP; Gaston KA; Boyoglu-Barnum S; Meng J; Stobart CC; Cotton CU; Hartert TV; Moore ML; Ziady AG; Anderson LJ
J Gen Virol; 2015 Sep; 96(9):2543-2556. PubMed ID: 26297201
[TBL] [Abstract][Full Text] [Related]
4. Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.
Johnson SM; McNally BA; Ioannidis I; Flano E; Teng MN; Oomens AG; Walsh EE; Peeples ME
PLoS Pathog; 2015 Dec; 11(12):e1005318. PubMed ID: 26658574
[TBL] [Abstract][Full Text] [Related]
5. m
Picavet LW; van Vroonhoven ECN; Scholman RC; Smits YTH; Banerjee R; Besteman SB; Viveen MC; van der Vlist MM; Tanenbaum ME; Lebbink RJ; Vastert SJ; van Loosdregt J
Viruses; 2024 May; 16(5):. PubMed ID: 38793659
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.
Chirkova T; Boyoglu-Barnum S; Gaston KA; Malik FM; Trau SP; Oomens AG; Anderson LJ
J Virol; 2013 Dec; 87(24):13466-79. PubMed ID: 24089561
[TBL] [Abstract][Full Text] [Related]
7. Marked induction of matrix metalloproteinase-10 by respiratory syncytial virus infection in human nasal epithelial cells.
Hirakawa S; Kojima T; Obata K; Okabayashi T; Yokota S; Nomura K; Obonai T; Fuchimoto J; Himi T; Tsutsumi H; Sawada N
J Med Virol; 2013 Dec; 85(12):2141-50. PubMed ID: 24009192
[TBL] [Abstract][Full Text] [Related]
8. Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.
Johnson CH; Miao C; Blanchard EG; Caidi H; Radu GU; Harcourt JL; Haynes LM
Comp Med; 2012 Feb; 62(1):14-20. PubMed ID: 22330646
[TBL] [Abstract][Full Text] [Related]
9. CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner.
Jeong KI; Piepenhagen PA; Kishko M; DiNapoli JM; Groppo RP; Zhang L; Almond J; Kleanthous H; Delagrave S; Parrington M
PLoS One; 2015; 10(6):e0130517. PubMed ID: 26107373
[TBL] [Abstract][Full Text] [Related]
10. Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response.
Hosakote YM; Brasier AR; Casola A; Garofalo RP; Kurosky A
J Virol; 2016 Nov; 90(21):9618-9631. PubMed ID: 27535058
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
Kishko M; Catalan J; Swanson K; DiNapoli J; Wei CJ; Delagrave S; Chivukula S; Zhang L
Virology; 2020 Nov; 550():21-26. PubMed ID: 32866728
[TBL] [Abstract][Full Text] [Related]
12. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
Harcourt JL; Karron RA; Tripp RA
J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
[TBL] [Abstract][Full Text] [Related]
14. Chemokine (C-X-C Motif) Ligand 4 Is a Restrictor of Respiratory Syncytial Virus Infection and an Indicator of Clinical Severity.
Han Z; Rao J; Xie Z; Wang C; Xu B; Qian S; Wang Y; Zhu J; Yang B; Xu F; Lei X; Guo F; Zhao Z; Ren L; Wang J
Am J Respir Crit Care Med; 2020 Sep; 202(5):717-729. PubMed ID: 32543879
[No Abstract] [Full Text] [Related]
15. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.
Amanatidou V; Sourvinos G; Apostolakis S; Tsilimigaki A; Spandidos DA
Pediatr Infect Dis J; 2006 May; 25(5):410-4. PubMed ID: 16645504
[TBL] [Abstract][Full Text] [Related]
16. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.
Guo X; Liu T; Shi H; Wang J; Ji P; Wang H; Hou Y; Tan RX; Li E
J Virol; 2015 Aug; 89(15):7636-45. PubMed ID: 25972545
[TBL] [Abstract][Full Text] [Related]
17. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity.
Zhivaki D; Lemoine S; Lim A; Morva A; Vidalain PO; Schandene L; Casartelli N; Rameix-Welti MA; Hervé PL; Dériaud E; Beitz B; Ripaux-Lefevre M; Miatello J; Lemercier B; Lorin V; Descamps D; Fix J; Eléouët JF; Riffault S; Schwartz O; Porcheray F; Mascart F; Mouquet H; Zhang X; Tissières P; Lo-Man R
Immunity; 2017 Feb; 46(2):301-314. PubMed ID: 28228284
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
Khan NA; Singla M; Samal S; Lodha R; Medigeshi GR
mSphere; 2020 May; 5(3):. PubMed ID: 32461278
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus infection of newborn CX3CR1-deficient mice induces a pathogenic pulmonary innate immune response.
Das S; Raundhal M; Chen J; Oriss TB; Huff R; Williams JV; Ray A; Ray P
JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878128
[TBL] [Abstract][Full Text] [Related]
20. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
